Gamma-globin gene promoter elements required for interaction with globin enhancers.

Normal expression of the human beta-globin domain genes is dependent on at least three types of regulatory elements located within the beta-globin domain: the locus control region (LCR), globin enhancer elements (3'beta and 3'Agamma), and the individual globin gene promoter and upstream regions. It has been postulated that regulation occurs through physical interactions between factors bound to these elements, which are located at considerable distances from each other. To identify the elements required for promoter-enhancer interactions from a distance, we have investigated the expression of the wild-type, truncated, and mutated gamma-globin promoters linked to the 5'HS2 enhancer. We show that in K562 cells, 5'HS2 increases activity approximately 20-fold from both a wild-type and truncated (-135 --> +25) gamma promoter and that truncation or site-directed mutagenesis of the tandem CCAAT boxes eliminated the enhancement by 5'HS2. Mutation of the gamma-globin gene promoter GATA-1 binding sites did not decrease either promoter strength or enhancement of activity by 5'HS2. To determine if enhanced expression of gamma-globin gene promoters carrying mutations associated with hereditary persistence of fetal hemoglobin (HPFH) was due to greater interactions with enhancers, we linked these HPFH gamma-globin gene promoters to 5'HS2 and demonstrated a twofold to threefold higher expression than the corresponding wild-type promoter plus enhancer in MEL cells. Addition of the Agamma-globin gene 3' enhancer to a plasmid containing the gamma-globin gene promoter and 5'HS2 did not further enhance promoter strength. Furthermore, we have demonstrated that the previously identified core 5'HS2 enhancer (46-bp tandem AP-1/NF-E2 sites) increased expression only when located 5', but not 3', to the gamma-globin-luciferase reporter gene, suggesting that its enhancer effect is not by DNA looping. Our results suggest that CCAAT boxes, but not GATA or CACCC binding sites, are required for interaction between the gamma-globin promoter and the LCR/5'HS2 and that regulatory elements in addition to the core enhancer may be required for the enhancer to act from a distance.

[1]  D. Bodine,et al.  A 46 base pair enhancer sequence within the locus activating region is required for induced expression of the gamma-globin gene during erythroid differentiation. , 1990, Nucleic acids research.

[2]  B. Cullen,et al.  Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. , 1988, Gene.

[3]  W. C. Forrester,et al.  Evidence for a locus activation region: the formation of developmentally stable hypersensitive sites in globin-expressing hybrids. , 1987, Nucleic acids research.

[4]  S. Fucharoen,et al.  A novel C-T transition within the distal CCAAT motif of the G gamma-globin gene in the Japanese HPFH: implication of factor binding in elevated fetal globin expression. , 1990, Nucleic acids research.

[5]  F. Collins,et al.  Nuclear proteins that bind the human gamma-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin , 1988, Molecular and cellular biology.

[6]  F. Studier,et al.  Use of T7 RNA polymerase to direct expression of cloned genes. , 1990, Methods in enzymology.

[7]  D. Tuan,et al.  Modulatory subdomains of the HS2 enhancer differentially regulate enhancer activity in erythroid cells at different developmental stages. , 1997, Blood cells, molecules & diseases.

[8]  S. Weissman,et al.  Different 3' end points of deletions causing delta beta-thalassemia and hereditary persistence of fetal hemoglobin: implications for the control of gamma-globin gene expression in man. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[9]  F. Grosveld,et al.  Detailed analysis of the site 3 region of the human beta‐globin dominant control region. , 1990, The EMBO journal.

[10]  T. Ley,et al.  Function of normal and mutated gamma-globin gene promoters in electroporated K562 erythroleukemia cells. , 1990, Blood.

[11]  R. Mantovani,et al.  A protein factor binding to an octamer motif in the gamma-globin promoter disappears upon induction of differentiation and hemoglobin synthesis in K562 cells. , 1987, Nucleic acids research.

[12]  F. Grosveld,et al.  Hypersensitive site 4 of the human β globin locus control region , 1991 .

[13]  K. Struhl,et al.  Current Protocols in Molecular Biology (New York: Greene Publishing Associates and Wiley-Interscience). Host-Range Shuttle System for Gene Insertion into the Chromosomes of Gram-negative Bacteria. , 1988 .

[14]  G. Schaffner,et al.  The −117 mutation in Greek HPFH affects the binding of three nuclear factors to the CCAAT region of the gamma‐globin gene. , 1988, The EMBO journal.

[15]  S. Orkin.  Globin gene regulation and switching: Circa 1990 , 1990, Cell.

[16]  T. Ikuta,et al.  In vivo protein-DNA interactions at the beta-globin gene locus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Raguz,et al.  Role of the duplicated CCAAT box region in gamma‐globin gene regulation and hereditary persistence of fetal haemoglobin. , 1996, The EMBO journal.

[18]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[19]  J. Bieker,et al.  Role of Erythroid Kruppel-like Factor in Human - to -Globin Gene Switching (*) , 1995, The Journal of Biological Chemistry.

[20]  C. Mazzucchelli,et al.  Differential Binding of the NFE3 and CP1/NFY Transcription Factors to the Human γ- and ε-Globin CCAAT Boxes (*) , 1995, The Journal of Biological Chemistry.

[21]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[22]  F. Grosveld,et al.  beta-globin dominant control region interacts differently with distal and proximal promoter elements. , 1990, Genes & development.

[23]  G. Stamatoyannopoulos,et al.  GATA1 and YY1 are developmental repressors of the human epsilon‐globin gene. , 1995, The EMBO journal.

[24]  A. Haese,et al.  Cooperation of GATA-1 and Sp1 can result in synergistic transcriptional activation or interference. , 1993, The Journal of biological chemistry.

[25]  R. Mantovani,et al.  Increased erythroid-specific expression of a mutated HPFH gamma-globin promoter requires the erythroid factor NFE-1. , 1989, Nucleic acids research.

[26]  F. Grosveld,et al.  Synthetic human beta‐globin 5′HS2 constructs function as locus control regions only in multicopy transgene concatamers. , 1993, The EMBO journal.

[27]  J. Clegg,et al.  K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin , 1979, Nature.

[28]  G. Stamatoyannopoulos,et al.  Developmental regulation of human gamma-globin genes in transgenic mice , 1993, Molecular and cellular biology.

[29]  M. Matsuda,et al.  Delta-thalassemia caused by disruption of the site for an erythroid-specific transcription factor, GATA-1, in the delta-globin gene promoter. , 1992, Blood.

[30]  Jeffrey H. Miller.  Experiments in molecular genetics , 1972 .

[31]  S. Nicolis,et al.  Increased Sp1 binding mediates erythroid-specific overexpression of a mutated (HPFH) gamma-globulin promoter. , 1989, Nucleic acids research.

[32]  R. Behringer,et al.  Multiple elements in human beta-globin locus control region 5' HS 2 are involved in enhancer activity and position-independent, transgene expression. , 1994, Nucleic acids research.

[33]  R. Treisman,et al.  Differences in human α- and β-globin gene expression in mouse erythroleukemia cells: The role of intragenic sequences , 1984, Cell.

[34]  A. Dean,et al.  Transcriptional role of a conserved GATA-1 site in the human epsilon-globin gene promoter , 1991, Molecular and cellular biology.

[35]  A. Nienhuis,et al.  Activation of the human beta-globin promoter in K562 cells by DNA sequences 5' to the fetal gamma- or embryonic zeta-globin genes. , 1987, Journal of Clinical Investigation.

[36]  L. Wall,et al.  Activation of the beta-globin promoter by the locus control region correlates with binding of a novel factor to the CAAT box in murine erythroleukemia cells but not in K562 cells , 1993, Molecular and cellular biology.

[37]  S. Karlsson,et al.  Promoter sequences required for function of the human gamma globin gene in erythroid cells. , 1986, The EMBO journal.

[38]  N. Martin,et al.  A single erythroid-specific DNase I super-hypersensitive site activates high levels of human beta-globin gene expression in transgenic mice. , 1989, Genes & development.

[39]  A. Nienhuis,et al.  The upstream region of the human gamma-globin gene promoter. Identification and functional analysis of nuclear protein binding sites. , 1991, The Journal of biological chemistry.

[40]  J. Kaysen,et al.  Protein-DNA interactions upstream from the human A gamma globin gene. , 1990, Nucleic acids research.

[41]  F. Grosveld,et al.  The beta‐globin dominant control region: hypersensitive site 2. , 1990, The EMBO journal.

[42]  S. Orkin,et al.  Increased γ-globin expression in a nondeletion HPFH mediated by an erythroid-specif ic DNA-binding factor , 1989, Nature.

[43]  Y. Kan,et al.  Synergistic enhancement of globin gene expression by activator protein-1-like proteins. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[44]  F. Collins,et al.  The -175T----C mutation increases promoter strength in erythroid cells: correlation with evolutionary conservation of binding sites for two trans-acting factors , 1990 .

[45]  S. Jane,et al.  Identification of a stage selector element in the human gamma‐globin gene promoter that fosters preferential interaction with the 5′ HS2 enhancer when in competition with the beta‐promoter. , 1992, The EMBO journal.

[46]  A. Brasier,et al.  Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. , 1989, BioTechniques.

[47]  K. Wood,et al.  Firefly luciferase gene: structure and expression in mammalian cells , 1987, Molecular and cellular biology.

[48]  D. Tuan,et al.  An erythroid-specific, developmental-stage-independent enhancer far upstream of the human "beta-like globin" genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[49]  F. Costantini,et al.  Roles of fetal G gamma-globin promoter elements and the adult beta-globin 3' enhancer in the stage-specific expression of globin genes , 1990, Molecular and cellular biology.

[50]  W. C. Forrester,et al.  A deletion of the human beta-globin locus activation region causes a major alteration in chromatin structure and replication across the entire beta-globin locus. , 1990, Genes & development.

[51]  T. Ley,et al.  Functional properties of the beta-globin locus control region in K562 erythroleukemia cells. , 1991, Blood.

[52]  F. Grosveld,et al.  The 5′HS2 of the globin locus control region enhances transcription through the interaction of a multimeric complex binding at two functionally distinct NF‐E2 binding sites. , 1991, The EMBO journal.

[53]  G. Felsenfeld,et al.  Chromatin as an essential part of the transcriptional mechanim , 1992, Nature.

[54]  G. Kollias,et al.  Position-independent, high-level expression of the human β-globin gene in transgenic mice , 1987, Cell.

[55]  J. Bieker,et al.  The erythroid Krüppel-like factor transactivation domain is a critical component for cell-specific inducibility of a beta-globin promoter , 1995, Molecular and cellular biology.

[56]  Frank Grosveld,et al.  A single point mutation is the cause of the Greek form of hereditary persistence of fetal haemoglobin , 1992, Nature.

[57]  J. D. Engel,et al.  Developmental regulation of β-globin gene switching , 1988, Cell.

[58]  D. Tuan,et al.  The "beta-like-globin" gene domain in human erythroid cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[59]  N. Roberts,et al.  Globin gene switching in transgenic mice carrying HS2-globin gene constructs. , 1997, Blood.

[60]  A. Nienhuis,et al.  Tandem AP-1-binding sites within the human beta-globin dominant control region function as an inducible enhancer in erythroid cells. , 1990, Genes & development.

[61]  Y. Kan,et al.  Human beta-globin gene expression in transgenic mice is enhanced by a distant DNase I hypersensitive site. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[62]  R. Mantovani,et al.  The effects of HPFH mutations in the human gamma-globin promoter on binding of ubiquitous and erythroid specific nuclear factors. , 1988, Nucleic acids research.

[63]  A. Nienhuis,et al.  Inducibility of the HS II enhancer depends on binding of an erythroid specific nuclear protein. , 1990, Nucleic acids research.

[64]  G. Stamatoyannopoulos,et al.  Genomic footprinting and sequencing of human beta-globin locus. Tissue specificity and cell line artifact. , 1994, The Journal of biological chemistry.

[65]  K. Sykes,et al.  A naturally occurring gamma globin gene mutation enhances SP1 binding activity , 1990, Molecular and cellular biology.

[66]  J. Lingrel,et al.  Mutations in two regions upstream of the A gamma globin gene canonical promoter affect gene expression. , 1989, Nucleic acids research.

[67]  Y. Fukumaki,et al.  A role for the distal CCAAT box of the gamma-globin gene in Hb switching. , 1995, Journal of biochemistry.

[68]  E. Bresnick,et al.  Evidence that the transcription factor USF is a component of the human beta-globin locus control region heteromeric protein complex. , 1993, The Journal of biological chemistry.

[69]  F. Grosveld,et al.  Nuclear protein factors and erythroid transcription of the human Aγ-globin gene , 1989 .

[70]  S. Jane,et al.  Methylation-enhanced binding of Sp1 to the stage selector element of the human gamma-globin gene promoter may regulate development specificity of expression , 1993, Molecular and cellular biology.